Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy

Fig. 5

Decision curve analysis of the nomogram for predicting pCR in breast cancer after NAC. The X-axis represents the risk threshold probability, and the Y-axis represents the net benefit. The decision curve analysis shows that the nomogram has a higher net benefit than the default treat-all and treat-none, indicating that the probability of pCR predicted by the nomogram is superior to either treat-all or none strategy. pCR: Pathological complete response; NAC: Neoadjuvant chemotherapy; WBC: White blood cell; PLT: Platelet; PLR: Platelet-to-lymphocyte ratio

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us